down arrow

Innova Captab

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE0DUT01020
  • NSEID: INNOVACAP
  • BSEID: 544067
INR
878.70
46.8 (5.63%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 39.86 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Innova Captab Ltd stock-summary
stock-summary
Innova Captab Ltd
Small Cap
Pharmaceuticals & Drugs
Innova Captab Limited was incorporated as `Harun Health Care Private Limited', dated January 3, 2005, as a Private Limited Company at Mumbai. Thereafter, the name of the Company was changed from `Harun Health Care Private Limited' to `Innova Captab Private Limited', and a fresh Certificate of Incorporation dated February 2, 2010, was issued by RoC to the Company.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 57.22 Cr
Number of Shares
5.72 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
27-Dec-2023
5.72
57.22
7142857
10
Public Issue
03-Dec-2023
5.01
50.08
669642
10
Private Placement
01-Dec-2023
4.94
49.41
1412430
10
Preference Share Conversion
27-Apr-2022
4.8
48.00
36000000
10
Bonus Issue
04-Apr-2022
1.2
12.00
10800000
10
Stock Split
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 9 Schemes (10.75%)

FIIs

Held by 15 FIIs (0.34%)

Promoter with highest holding

Manoj Lohariwala (29.07%)

Highest Public shareholder

Gian Parkash Aggarwal (21.65%)

Individual Investors Holdings

27.62%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
316 Cr
(Quarterly Results - Dec 2024)
Net Profit:
34 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 5,028 Cr (Small Cap)

stock-summary
P/E

37.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.27

stock-summary
Return on Equity

13.22%

stock-summary
Price to Book

5.32